Epignostix raises €4.3M Seed round
2 July 2024· Heidelberg, Germany· health, oncology, ai, biotech, b2b, pure_software
The funding will be used to commercialize the company's diagnostic tumor classifier, drive market development for its flagship brain tumor classification product, and support R&D, certification, and marketing efforts.
Investors
LeadCARMA FUND I Capital
Also participating
High-Tech GründerfondsLBBW Venture CapitalStart-up BW Seed Fonds
About Epignostix
Stage
Seed
Headquarters
Heidelberg, Germany
Founded
2022
Team Size
6–20
Sectors
healthoncologyaibiotechb2bpure_software